Caring Brands (CABR) Net Income towards Common Stockholders (2024 - 2026)

Caring Brands' (CABR) quarterly Net Income towards Common Stockholders came in at -$3.9 million in Q1 2026, down 615.16% year-on-year from $747934.9 in Q1 2025, and down 3.13% quarter-over-quarter from -$3.7 million in Q4 2025.

Caring Brands (CABR) Net Income towards Common Stockholders (2024 - 2026) Analysis & Trends

Caring Brands' Net Income towards Common Stockholders history runs 3 years deep, the most recent figure standing at -$3.9 million for Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders fell 615.16% year-over-year to -$3.9 million in Q1 2026; TTM through Mar 2026 was -$9.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$7.4 million, down 2740.12% from the prior year.
  • Net Income towards Common Stockholders declined to -$3.9 million in Q1 2026 per CABR's latest filing, from -$3.7 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at -$428906.0 in Q3 2024 and bottomed at -$3.9 million in Q1 2026.
  • The 3-year median for Net Income towards Common Stockholders is -$1.3 million (2024), against an average of -$1.8 million.
  • Across the five-year window, Net Income towards Common Stockholders slumped 283.88% in 2025 and tumbled 615.16% in 2026, its largest moves.
  • Year by year, Net Income towards Common Stockholders stood at -$862791.0 in 2024, then slumped by 333.02% to -$3.7 million in 2025, then declined by 3.13% to -$3.9 million in 2026.
  • Per Business Quant, the three latest CABR Net Income towards Common Stockholders figures stand at -$3.9 million (Q1 2026), -$3.7 million (Q4 2025), and -$1.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Haleon 89.78 Bn 87.91 Bn - -
2 Teva Pharmaceutical Industries 36.02 Bn 32.28 Bn 1.97 Bn 370.00 Mn
3 Zoetis 32.60 Bn 30.66 Bn 1.62 Bn 601.00 Mn
4 Takeda Pharmaceutical 27.54 Bn 23.48 Bn 4.39 Bn -2.35 Bn
5 United Therapeutics 23.09 Bn 20.94 Bn 648.10 Mn 274.90 Mn
6 RedHill Biopharma 21.48 Bn 21.48 Bn - -
7 Viatris 20.35 Bn 18.54 Bn 1.16 Bn 176.40 Mn
8 Neurocrine Biosciences 17.82 Bn 16.50 Bn 800.70 Mn 197.90 Mn
9 Elanco Animal Health 12.64 Bn 12.21 Bn 785.00 Mn 57.00 Mn
10 Caring Brands 20.66 Mn 18.63 Mn - -3.85 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.85 Mn
Dec 31, 2025 -3.74 Mn
Sep 30, 2025 -1.65 Mn
Mar 31, 2025 -538,770.00
Dec 31, 2024 -862,791.00
Sep 30, 2024 -428,906.00